Sentence examples for path to approval from inspiring English sources

As the first overhaul of patent laws in six decades, the bill appears to be on a bipartisan path to approval in both houses of Congress, each of which has approved similar legislation in the past.

Considering each reactor separately turned into a time-consuming process without any clear path to approval.

Any delay could complicate the deal's path to approval as attention turns to the 2020 presidential campaign.

There is no sign of a long-term budget deal, a Senate-passed immigration plan has no clear path to approval in the House and legislation to expand background checks on guns went down in an embarrassing defeat.

Patent 8,086,604's path to approval "shows there's a lot wrong with the process," said Arti K. Rai, an intellectual property expert at Duke University School of Law who reviewed the patent application for The Times.

The bill -- which passed 219 to 206, with three dozen Democrats joining all but two Republicans in opposition -- took an unexpectedly difficult path to approval in the House and now faces an uncertain fate in the Senate.

Since then Quest has tried to smooth the path to approvals by bringing in medical providers early in the game, from R&D efforts to initial trials and marketing.

Drug repositioning most attractive feature is its ability to reduce costs and provide shorter paths to approval compared to the daunting traditional techniques.

This strategy certainly has the potential of being the most efficient technique for drug discovery since it provides reduced development costs and shorter paths to approval [2].

Computational approaches may play significant roles in reducing the developmental costs and shortening the paths to approval, for example, to facilitate drug repositioning.

These devices compare favorably with the EpiPen in size and ease-of-use, but no manufacturer has applied to bring them to the U.S. Despite recent attempts to "harmonize" the approval pathways between EU regulators and FDA, the path to U.S. approval for an approved EU device remains long, costly and uncertain.